Sanket Koul &Amp;Amp; Anjali Singh

Stories by Sanket Koul &Amp;Amp; Anjali Singh

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com   31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

Weight-Loss Drug Battle Intensifies

Weight-Loss Drug Battle Intensifies

Rediff.com   22 Jul 2025

'Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five times what it was five years ago.'

AdFalciVax Is India's Malaria Vaccine

AdFalciVax Is India's Malaria Vaccine

Rediff.com   21 Jul 2025

'AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing single-stage malaria vaccines.'

Illinois Tech To Open Mumbai Campus Next Year

Illinois Tech To Open Mumbai Campus Next Year

Rediff.com   18 Jul 2025

At the Mumbai campus the institute will offer both UG and graduate degrees, most of its courses will focus on science, technology, engineering and mathematics.

Realty market saw land deals worth Rs 31,000 cr in H1 2025: Anarock

Realty market saw land deals worth Rs 31,000 cr in H1 2025: Anarock

Rediff.com   16 Jul 2025

At least 2,900 acres of land deals, with a market value of Rs 31,000 crore, were transacted in the Indian realty market during the first six months of 2025 (H1 2025), according to a report by real estate analytics firm Anarock. These deals include both outright transactions as well as joint development agreements between realtors and landowners.

Why Students Are Pausing US Plans

Why Students Are Pausing US Plans

Rediff.com   14 Jul 2025

Many students are now looking at opportunities in the UK, Australia, and Singapore due to lower cost of living and less interference from the government.

Wockhardt exits US generics biz, to focus on innovation

Wockhardt exits US generics biz, to focus on innovation

Rediff.com   12 Jul 2025

Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.

Mahindra e-SUVs Can Now Drive Upto 500 km On Single Charge

Mahindra e-SUVs Can Now Drive Upto 500 km On Single Charge

Rediff.com   11 Jul 2025

Customers who have already booked earlier variants will also have the option to upgrade to the 79 kWh battery version.

Now, You Can Study In A UK College... In India

Now, You Can Study In A UK College... In India

Rediff.com   9 Jul 2025

At least six major UK universities have announced plans to set up campuses or liaison offices in India.

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com   30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

Govt To Target Coaching Centres

Govt To Target Coaching Centres

Rediff.com   23 Jun 2025

The panel will examine the reasons behind the emergence of dummy schools and their role in encouraging full-time coaching at the cost of formal schooling, and will suggest ways to mitigate the issue.

Hospitals Boost IT Spend to Fight Cyber Threats

Hospitals Boost IT Spend to Fight Cyber Threats

Rediff.com   20 Jun 2025

The growing caution among hospitals is being driven by a rise in double-extortion ransomware attacks, AI-enabled phishing, deepfake fraud, and vulnerabilities in connected medical devices.

Real estate giant DLF aims to launch Mumbai project by next quarter

Real estate giant DLF aims to launch Mumbai project by next quarter

Rediff.com   19 Jun 2025

DLF will officially launch its Mumbai housing project in the next quarter as the company has received the RERA approval a day before, while the real estate major sold out all 1,164 units in its luxury residential project Privana North securing Rs 11,000 crore revenue, DLF Homes joint managing director and chief business officer Aakash Ohri said.

Germany Courts Indian Students, But...

Germany Courts Indian Students, But...

Rediff.com   18 Jun 2025

'We want quality... you have to be very good in your application and then only the university will accept it.'

TaMo eyes 40% CV, 16% PV market share

TaMo eyes 40% CV, 16% PV market share

Rediff.com   17 Jun 2025

Tata Motors (TaMo) is aiming to gain market share across its passenger vehicle (PV) and commercial vehicle (CV) businesses - targeting a 40 per cent share in CVs and a 16 per cent share in PVs by 2027. Meanwhile, it has already achieved earnings before interest, tax, depreciation, and amortisation (Ebitda) breakeven in its electric vehicle (EV) business at 1.2 per cent (up 830 basis points), ahead of its target of 2025-26 (FY26).

Indian Students Caught In US Visa Turmoil

Indian Students Caught In US Visa Turmoil

Rediff.com   16 Jun 2025

Uncertainty clouds US fall intake as Trump's visa ban on Harvard raises fears of wider policy shifts, pushing Indian students to explore alternative destinations.

Rare earth inventories may run dry by mid-July

Rare earth inventories may run dry by mid-July

Rediff.com   13 Jun 2025

Inventories of rare earth magnets used in critical automotive components - particularly electric vehicle (EV) traction motors and power steering systems - could run dry by mid-July this year, according to rating agency Icra.

HDFC Bank to pursue legal remedies against Mehta family of Lilavati Trust

HDFC Bank to pursue legal remedies against Mehta family of Lilavati Trust

Rediff.com   9 Jun 2025

HDFC Bank on Sunday said that it will "pursue all lawful remedies" to recover public funds and address the retaliatory actions taken by the Mehta family of the Lilavati Kirtilal Mehta Medical (LKMM) Trust, which has filed a complaint against the bank's managing director (MD) & chief executive officer (CEO) Sashidhar Jagdishan alleging financial fraud.

US Visa Hurdles Delay Study Dreams

US Visa Hurdles Delay Study Dreams

Rediff.com   6 Jun 2025

'Such unpredictability is motivating families to seek destinations with a more stable educational system.'

'Ready To Launch 5 products In 18 Months'

'Ready To Launch 5 products In 18 Months'

Rediff.com   5 Jun 2025

'We recently launched Yesintek in the immunology space.'